1. Home
  2. RDHL vs AMIX Comparison

RDHL vs AMIX Comparison

Compare RDHL & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • AMIX
  • Stock Information
  • Founded
  • RDHL 2009
  • AMIX 2014
  • Country
  • RDHL Israel
  • AMIX United States
  • Employees
  • RDHL N/A
  • AMIX N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • AMIX
  • Sector
  • RDHL Health Care
  • AMIX
  • Exchange
  • RDHL Nasdaq
  • AMIX NYSE
  • Market Cap
  • RDHL 6.8M
  • AMIX 5.5M
  • IPO Year
  • RDHL N/A
  • AMIX N/A
  • Fundamental
  • Price
  • RDHL $4.76
  • AMIX $2.97
  • Analyst Decision
  • RDHL
  • AMIX
  • Analyst Count
  • RDHL 0
  • AMIX 0
  • Target Price
  • RDHL N/A
  • AMIX N/A
  • AVG Volume (30 Days)
  • RDHL 9.0K
  • AMIX 58.5K
  • Earning Date
  • RDHL 04-07-2025
  • AMIX 02-13-2025
  • Dividend Yield
  • RDHL N/A
  • AMIX N/A
  • EPS Growth
  • RDHL N/A
  • AMIX N/A
  • EPS
  • RDHL N/A
  • AMIX N/A
  • Revenue
  • RDHL $3,707,000.00
  • AMIX N/A
  • Revenue This Year
  • RDHL $224.90
  • AMIX N/A
  • Revenue Next Year
  • RDHL $82.69
  • AMIX N/A
  • P/E Ratio
  • RDHL N/A
  • AMIX N/A
  • Revenue Growth
  • RDHL N/A
  • AMIX N/A
  • 52 Week Low
  • RDHL $4.76
  • AMIX $2.55
  • 52 Week High
  • RDHL $20.28
  • AMIX $93.80
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 26.11
  • AMIX 47.86
  • Support Level
  • RDHL $5.20
  • AMIX $2.76
  • Resistance Level
  • RDHL $5.50
  • AMIX $2.95
  • Average True Range (ATR)
  • RDHL 0.23
  • AMIX 0.16
  • MACD
  • RDHL -0.07
  • AMIX 0.08
  • Stochastic Oscillator
  • RDHL 0.00
  • AMIX 72.83

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: